Introduction
Multiple myeloma (MM) is a hematological disorder caused by the emergence of a malignant clone of plasma cells, a mature form of B lymphocytes. The disease is frequently preceded by a phase of monoclonal gammopathy characterized by the presence of a paraprotein in the serum of the patients, but without signs or symptoms of illness. Since 1 -2%!yea r of the patients with paraproteinemia develop MM , most authors use the term "monoclonal gammopathy of unknown significance" (MGUS).
In order to get clinically relevant indicators for the prognosis and treatment of myeloma patients, Durie and Salmon established a staging system which correlates well with the estimated total number of malignant cells (1) . Additional factors were found to correlate with the prognosis, e. g .. the labeling index indicating the percentage of proliferating plasma cells in the bone marrow (2), and the serum concentration of beta-2-microglobulin, which has been shown to be produced by myeloma cultures in vitro (3, 4) . D-erythro-neopterin is secreted by monocytes/macrophages upon stimulation with interferon gamma (5) . Thi s effect can be sy nergisticall y enhanced by tumor necrosis factor alpha (6) . Neopterin has been shown to be of prognostic value in Hodgkin's disease, nonHodgkin's lymphoma and chronic myelogenous leukemia (7, 8) .
The aim of this study was to analyse the diagnostic value of urinary neopterin in patients . with MGUS and multiple myeloma.
Patients and Methods

PUlien lS
51 patients were included in this study. All of them had monoclonal gammopathy confirmed by immunoelectrophoresis of serum and/or urine. 41 patients (80%) suffered from MM , 10 patients had MGUS. MM was excluded in these patients by bone marrow examination « 10% plasma cells), bone radiography (lack of osteolytic lesions) and a stable course of the myeloma-protein. Staging of MM was performed according to the sys tem of Salmon and Durie (1).
Characteristics of patients are summarized in Table  1 . None of th e patients with MGUS was treated. Out of the patients with MM , 10/41 were evaluated at the time of diagnosis, 8/41 had no treatment because of remission or stable disease. The other 23 were under 
Analytical procedures
Hemoglobin and leukocytes were routinely evaluated from fresh blood samples using a cell counter (Coulter, Miami, FL USA). Differential counts were done by examination of stained blood smears. Beta-2-microglobulin was measured using a commercially available radioimmunoassay (Pharmacia, Uppsala, Sweden). Neopterin was determined by an optimized and fully automated high pressure liquid chromatography technique without previous oxidative treatment as described elsewhere (9) . By this reverse-phase technique, urinary creatinine is simultaneously determined in the same urine specimen. To account for variations of urine concentrations, neopterin levels are expressed as I1mol /mol creatinine.
Statistics
For the evaluation of differences between various groups of patients we used Kruskal-Wallis rank sum test. To define the strength and significance of correlations we computed Spearman's rank correlation coefficients. Table : 2) Neopterin and beta-2-microglobulin In MGUS patients the mean neopterin value was below the upper normal limit. In contrast, in MM patients the mean value was clearly elevated. Due to the high standard deviations, the difference between 
Results
Neop/erin. hct{{-:2-microglobllIiJl {{nd hema/ological vallies (
Hemoglobin, monocytes and peripheral lymphocytes
Hemoglobin concentrations and total number of peripheral lymphocytes were significantly lower in M M of advanced stage than in MGUS and stage I MM (p < 0.001 and p = 0.035 , respectively), whereas the number of peripheral monocytes was not different (p = 0.388).
Correlation hetll'ccn I1coprerin . heta-2-nzicroglobulin {lnd hematological paramerers
Correlating neopterin with the other values we found a significant negative correlation between neopterin and the hemoglobin concentrations (r = -0.542, p = < 0.05). A positive correlation was seen between neopterin and the number of peripheral monocytes (r = 0.38, p < 0.05), whereas a correlation with lymphocytes was not found. Beta-2-microglobulin correlated with hemoglobin values in a similar manner as neopterin (r= -0.702, p= <0.01). Finally we observed a significant positive correlation between neopterin and beta-2-microglobulin (r = 0.53, p < 0.05) .
Discussion
Our data show elevated concentrations of urinary neopterin and beta-2-microglobulin in patients with MM, especially in patients with more advanced dis- Table 2 . Urinary neopterin. beta-2-microglobulin and hematological parameters in patients with MGUS and multiple myeloma ease. Similar results havc been described by others (10 -12) . From our data the question remains open. if neopterin is of special va lue in the differential diagnosis between MG U S and MM. since we havc found similar values in MGUS and MM stage l. Nevertheless, increased va lues renect a significant activity of the disease and may represent an additional parameter, e. g., for the deci sio n if therapy is necessary or not.
The close correlation betwee n neopterin and beta-2-microglobulin argues in favor of a similar clinical relevance of both markers. additionally neopterin is not dependent on the renal function. since neopterin values arc related to urinary creatinine. Thomas (11 ) found that urinary neopterin concentrations correla te even stronger with the calculated tumor cell mass th a n beta-2-microglobulin .
Previous results have shown a negative correlation between hemoglobin and neopterin values (13) pointing to a potential role of immunological factors in the pathogenesis of anemia in hematological disorders . These data have been confirmed also in the prese nt analysis of patients with \1 GU S and MM. Anemia in these patients might be not only due to bone marrow replacement. bu t mediated by a number of cytokines. e. g., interfero n gamma or tumor necrosis factor, although we found a correlation between the degree of bone marrow infi ltration by plasma cells and that of anemia (data not shown).
Elevated neopterin values are a sign of activation of ccll mediated immunity. Therefore our data raise the question . whether the monocyte/ macrophage system is activated in the framework of an -ineffectiveimmune reaction against the tumor or whether elevated neopterin concentrations result from macroph age activation by cytokines produced by the mali gnant cells themselves .
These two aspects. the clinical relevance on the one hand and the expression of an activation status o f monocytes!macrophages on the other hand. ma ke neopterin an interesting ma rker in monoclonal gammopathies.
